Table 2.
Secondary Causes of Hepatic Steatosis
| Diseases |
| Alcohol-related liver disease (ALD) |
| Hepatitis C viral infection (genotype 3) |
| Wilson’s disease |
| Abetalipoproteinemia, hypobetalipoproteinemia |
| Lipodystrophy |
| Long-term starvation |
| Lecithin-cholesterol acyltransferase (LCAT) deficiency |
| Cholesterol ester storage disease |
| Drugs |
| Macrovesicular steatosis |
| Amiodarone |
| Corticosteroid |
| Methotrexate |
| Chemotherapeutic agents (Tamoxifen, 5-Fluorouracil, Irinotecan, Cisplatin, Asparaginase) |
| Total parenteral nutrition |
| Microvesicular steatosis |
| Tetracycline |
| Valproic acid |
| Nucleoside reverse transcriptase inhibitors |
| Corticosteroid |
| Cocaine |
| Steatohepatitis |
| Amiodarone |
| Methotrexate |
| Tamoxifen |
| Irinotecan |
ALD: Alcohol-related liver disease; LCAT: Lecithin-cholesterol acyltransferase.